New Distributors: First Look?
Is this going ot be the first look at the success of the new distribution relationships?
Response Biomedical Corp. Schedules First Quarter 2013 Earnings Release and Conference Call and Announces Participation in Upcoming Investor Conference
Vancouver, British Columbia, May 7, 2013 – Response Biomedical Corp. ("Response") (TSX: RBM, OTCBB: RPBIF) will release its first quarter 2013 financial results after the markets close on Monday, May 13, 2013.
Jeffrey L. Purvin, Chief Executive Officer, will host a conference call to discuss the Q1, 2013 financial results on May 13, 2013 at 2:00 p.m. PDT (5:00 p.m. EDT), shortly after the initial release. Also participating in the call will be Bill Adams, Chief Financial Officer.
The conference call will be webcast live and is also available by dialing 1-877-643-7155 in North America or 1-914-495-8552 for all other locations. The conference ID number is 64770721 and participants are encouraged to initiate their calls at least 10 minutes in advance of the 2:00 p.m. PDT (5:00 p.m. EDT) start time to ensure a timely connection.
The live webcast and earnings release will be accessible from our website: www.responsebio.com/events. A replay of the conference call will also be available online approximately two hours after the call and for 90 days thereafter.
Additionally, Response announces that Jeffrey L. Purvin, Chief Executive Officer, will be presenting at the Bloom Burton & Co. Healthcare Investor Conference to be held at the Toronto Board of Trade, Toronto, Ontario, Canada, on Wednesday, May 22, 2013 at 3:30 p.m. EDT.